Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Multiple Myeloma × fludarabine × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

OTHER 69 INDUSTRY 23 NIH 6 OTHER_GOV 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 6 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Myelodysplastic Syndromes 4 Leukemia, Lymphocytic, Chronic, B-Cell 4 Leukemia, Biphenotypic, Acute 4 Leukemia 3 Preleukemia 2 Precancerous Conditions 2 Neoplasms by Histologic Type 2 Neoplasms 2 Lymphoproliferative Disorders 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma 2 Lymphatic Diseases 2 Leukemia, Myeloid 2 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2 Leukemia, Lymphoid 2 Leukemia, B-Cell 2 Immunoproliferative Disorders 2 Immune System Diseases 2 Hematologic Diseases 2 Bone Marrow Diseases 2 Triple Negative Breast Neoplasms 1 Sarcoma, Alveolar Soft Part 1 Primary Myelofibrosis 1 Myeloproliferative Disorders 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Follicular 1 Leukemia, Prolymphocytic 1

Interventions

Dexamethasone 39 Bortezomib 20 Lenalidomide 17 Cyclophosphamide 17 daratumumab 14 Thalidomide 11 Melphalan 11 Calcium Dobesilate 11 Prednisone 7 carfilzomib 6 Peripheral Blood Stem Cell Transplantation 6 pomalidomide 5 Doxorubicin 5 dexamethasone acetate 4 dexamethasone 21-phosphate 4 auricularum 4 Filgrastim 4 Vincristine 3 Interferon-alpha 3 selinexor 2 sargramostim 2 ixazomib 2 isatuximab 2 elotuzumab 2 cobimetinib 2 Steroids 2 Radiotherapy 2 Microarray Analysis 2 Gene Expression Profiling 2 Etoposide 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05257083 2026-03-17

CARTITUDE-6

European Myeloma Network B.V.

Phase 3 Active not recruiting

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡